Publications - IR Sant Pau

Search

01/11/2021 Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2

Ruiz-Rodriguez, P, Frances-Gomez, C, Chiner-Oms, A, Lopez, MG, Jimenez-Serrano, S, Cancino-Munoz, I, Ruiz-Hueso, P, Torres-Puente, M, Bracho, MA, D'Auria, G, Martinez-Priego, L, Guerreiro, M, Montero-Alonso, M, Gomez, MD, Pinana, JL, Gonzalez-Candelas, F, Comas, I, Marina, A, Geller, R, Coscolla, M, Rabella N., Navarro F., Miró E., SeqCOVID Spain Consortium. Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2. mBio. 2021; 12(6)DOI:10.1128/mBio.02315-21. PMID:34781748. IF:7.786(Q1/2D).

01/11/2021 Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain

Barca, LV, Vidal-Bonnet, L, Farinas, MC, Munoz, P, Minero, MV, de Alarcon, A, Carretero, EG, Cuadra, MG, Camacho, AM, Urkola, XK, Agirre, JG, Burgos, GO, Lopez-Cortes, LE, Azpiroz, JCP, Lopez-Menendez, J, Benito N., GAMES Investigators. Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain. HEART. 2021; 107(21)DOI:10.1136/heartjnl-2021-319254. PMID:34290038. IF:7.369(Q1/3D).

01/11/2021 Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis

Cortes-Lara, S, del Barrio-Tofino, E, Lopez-Causape, C, Oliver, A, Rivera A., GEMARA-SEIMC REIPI Pseudomonas S. Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(11)DOI:10.1016/j.cmi.2021.05.011. PMID:34015532. IF:13.310(Q1/1D).

06/10/2021 Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study

Kraef, C, Bentzon, A, Panteleev, A, Skrahina, A, Bolokadze, N, Tetradov, S, Podlasin, R, Karpov, I, Borodulina, E, Denisova, E, Azina, I, Lundgren, J, Johansen, IS, Mocroft, A, Podlekareva, D, Kirk, O, Pomar V., Millet J.P., Orcau A., TB HIV Study Grp. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study. BMC INFECTIOUS DISEASES. 2021; 21(1)DOI:10.1186/s12879-021-06745-w. PMID:34615474. IF:3.669(Q3/7D).

01/09/2021 Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score

Berenguer, J, Borobia, AM, Ryan, P, Rodriguez-Bano, J, Bellon, JM, Jarrin, I, Carratala, J, Pachon, J, Carcas, AJ, Yllescas, M, Arribas, JR, López-Contreras J., Pascual, P., Pomar V., Rabella N., Benito N., Domingo P., Bonfill X., Mancebo J., MARTIN VEGA, ALBERTO. Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score. THORAX. 2021; 76(9)DOI:10.1136/thoraxjnl-2020-216001. PMID:33632764. IF:9.203(Q1/2D).

01/08/2021 Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

Escribano, P, Rodriguez-Sanchez, B, Diaz-Garcia, J, Martin-Gomez, MT, Ibanez-Martinez, E, Rodriguez-Mayo, M, Pelaez, T, de la Pedrosa, EGG, Tejero-Garcia, R, Marimon, JM, Reigadas, E, Rezusta, A, Labayru-Echeverria, C, Perez-Ayala, A, Ayats, J, Cobo, F, Pazos, C, Lopez-Soria, L, Alastruey-Izquierdo, A, Munoz, P, Guinea, J, Sánchez-Reus F., Hernaez Crespo, Silvia. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain. CLINICAL MICROBIOLOGY AND INFECTION. 2021; 27(8)DOI:10.1016/j.cmi.2020.09.042. PMID:33010446. IF:13.310(Q1/1D).

29/07/2021 Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Hodcroft, EB, Zuber, M, Nadeau, S, Vaughan, TG, Crawford, KHD, Althaus, CL, Reichmuth, ML, Bowen, JE, Walls, AC, Corti, D, Bloom, JD, Veesler, D, Mateo, D, Hernando, A, Comas, I, Candelas, FG, Stadler, T, Neher, RA, Rabella N., Navarro F., Miró E., Fernandez-Cadenas I, Parra Grande, Monica. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. NATURE. 2021; 595(7869)DOI:10.1038/s41586-021-03677-y. PMID:34098568. IF:69.504(Q1/1D).

01/07/2021 Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure

Soler, MJ, Noordzij, M, Abramowicz, D, de Arriba, G, Basile, C, van Buren, M, Covic, A, Crespo, M, Duivenvoorden, R, Massy, ZA, Ortiz, A, Sanchez, JE, Petridou, E, Stevens, K, White, C, Vart, P, Gansevoort, RT, Canal C., Facundo C., ERACODA Collaborators. Renin-Angiotensin System Blockers and the Risk of COVID-19-Related Mortality in Patients with Kidney Failure. Clinical Journal of the American Society of Nephrology. 2021; 16(7)DOI:10.2215/CJN.18961220. PMID:34088718. IF:10.624(Q1/1D).

01/08/2024 Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.

Larrosa MN, Canut-Blasco A, Benito N, Cantón R, Cercenado E, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Morosini MI, Navarro F, Martínez-Martínez L, Oliver A. Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports.. Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2024; 41(7)DOI:10.1016/j.eimce.2022.09.002. PMID:36175285. IF:(Q/D).

01/11/2023 Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion.

Rivera A, Viñado B, Benito N, Docobo-Pérez F, Fernández-Cuenca F, Fernández-Domínguez J, Guinea J, López-Navas A, Moreno MÁ, Larrosa MN, Oliver A, Navarro F. Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion.. Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2023; 41(9)DOI:10.1016/j.eimce.2022.12.009. PMID:36610835. IF:(Q/D).

01/10/2023 Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.

Ruiz-Ramos J, Herrera-Mateo S, Rivera-Martínez MA, Monje-López AE, Hernández-Ontiveros H, Pereia-Batista CS, Martinez-Ysasis YM, Puig-Campmany M. Programa de optimización de antibioterapia en infección urinaria por cepas multirresistentes en el servicio de urgencias.. Revista Espanola de Quimioterapia. 2023; 36(5)DOI:10.37201/req/009.2023. PMID:37458335. IF:1.900(Q3/7D).

06/09/2023 In Vitro Effect of Three-Antibiotic Combinations plus Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium and Mycobacterium intracellulare Clinical Isolates.

Batista S, Fernandez-Pittol M, Nicolás LS, Martínez D, Rubio M, Garrigo M, Vila J, Tudó G, González-Martin J. In Vitro Effect of Three-Antibiotic Combinations plus Potential Antibiofilm Agents against Biofilm-Producing Mycobacterium avium and Mycobacterium intracellulare Clinical Isolates.. Antibiotics-Basel. 2023; 12(9)DOI:10.3390/antibiotics12091409. PMID:37760706. IF:4.300(Q1/2D).

28/08/2023 Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.

Marais LC, Nieuwoudt L, Nansook A, Menon A, Benito N. Tuberculous arthritis of native joints - a systematic review and European Bone and Joint Infection Society workgroup report.. Journal Of Bone And Joint Infection. 2023; 8(4)DOI:10.5194/jbji-8-189-2023. PMID:37780528. IF:(Q/D).

01/01/2023 Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.

Espíndola R, Vella V, Benito N, Mur I, Tedeschi S, Zamparini E, Hendriks JGE, Sorlí L, Murillo O, Soldevila L, Scarborough M, Scarborough C, Kluytmans J, Ferrari MC, Pletz MW, McNamara I, Escudero-Sanchez R, Arvieux C, Batailler C, Dauchy FA, Liu WY, Lora-Tamayo J, Praena J, Ustianowski A, Cinconze E, Pellegrini M, Bagnoli F, Rodríguez-Baño J, Dolores Del Toro M. Incidence, associated burden of disease, and healthcare utilisation of prosthetic joint infections due to Staphylococcus aureus in European hospitals. The COMBACTE-NET ARTHR-IS multicentre study.. JOURNAL OF HOSPITAL INFECTION. 2023; 142DOI:10.1016/j.jhin.2023.09.012. PMID:37797656. IF:3.900(Q1/2D).

01/01/2023 Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.

Grillo S, Pujol M, Miró JM, López-Contreras J, Euba G, Gasch O, Boix-Palop L, Garcia-País MJ, Pérez-Rodríguez MT, Gomez-Zorrilla S, Oriol I, López-Cortés LE, Pedro-Botet ML, San-Juan R, Aguado JM, Gioia F, Iftimie S, Morata L, Jover-Sáenz A, García-Pardo G, Loeches B, Izquierdo-Cárdenas Á, Goikoetxea AJ, Gomila-Grange A, Dietl B, Berbel D, Videla S, Hereu P, Padullés A, Pallarès N, Tebé C, Cuervo G, Carratalà J. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.. NATURE MEDICINE. 2023; 29(10)DOI:10.1038/s41591-023-02569-0. PMID:37783969. IF:58.700(Q1/1D).

01/11/2021 COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study

Goffin, E, Candellier, A, Vart, P, Noordzij, M, Arnol, M, Covic, A, Lentini, P, Malik, S, Reichert, LJ, Sever, MS, Watschinger, B, Jager, KJ, Gansevoort, RT, Canal C., Facundo C., ERACODA Collaborators. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021; 36(11)DOI:10.1093/ndt/gfab200. PMID:34132811. IF:7.186(Q1/2D).

10/02/2026 A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin

Rovira, I, Montemayor, E, Gil-Alonso, S, Miranda-Cadena, K, Sanchez-Reus, F, Quindos, G, Eraso, E, Jauregizar, N. A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin. ACS Omega. 2026; 11(5)DOI:10.1021/acsomega.5c10111. PMID:41696345. IF:4.300(Q2/4D).

01/02/2026 Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study

Pérez, MAC, Grillo, S, Rombauts, A, Martinez, MAR, Falcó-Roget, A, Albasanz-Puig, A, Viñado-Pérez, B, Fernández-Hidalgo, N, Camps-Relats, L, Bergas, A, Laporte-Amargos, J, López-Contreras, J, Escolà-Vergé, L. Risk of infective endocarditis in oncohaematological patients undergoing active treatment with Enterococcus faecalis bloodstream infection: A retrospective multicentre study. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2026; 67(2)DOI:10.1016/j.ijantimicag.2025.107706. PMID:41456670. IF:4.600(Q1/2D).

01/01/2026 Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study

Piriz-Marabajan, M, Rombauts, A, Roch-Villaverde, N, Cortes-Palacios, AP, Fernandez-Piqueras, E, Serrano-Condal, S, Taltavull-Menendez, M, Grillo, S, Simonetti, AF, Duch, P, Pomar-Solchaga, V, Escolà-Vergé, L, Lopez-Contreras, J. Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study. JOURNAL OF HOSPITAL INFECTION. 2026; 167DOI:10.1016/j.jhin.2025.09.009. PMID:41075840. IF:3.100(Q1/3D).

14/12/2025 Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit

Monje, A, Escolà-Vergé, L, Rivera, A, Herrera, S, Plaza, A, Duch-Llorach, P, Pomar, V, Roch, N, Rouras, L, Lopez-Contreras, J, Ramos, JR. Targeting Overtreatment of Asymptomatic Bacteriuria in the Emergency Department: Results from a Quasi-Experimental Clinical Pharmacist-Led Program Based on Education and Audit. Antibiotics-Basel. 2025; 14(12)DOI:10.3390/antibiotics14121261. PMID:41463763. IF:4.600(Q1/2D).

01/12/2025 Vibrio fluvialis cholangitis with bacteremia and refractory septic shock: a case report and review of the literature

Lazzari, R, Cano, MB, Martínez, AR, Bueno, MR, Rovira, MC, Campmany, MP. Vibrio fluvialis cholangitis with bacteremia and refractory septic shock: a case report and review of the literature. INFECTION. 2025; 53(6)DOI:10.1007/s15010-025-02535-7. PMID:40377851. IF:3.600(Q2/3D).

01/12/2025 Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol

Casares, LD, Pereiro, JE, Fernández, MTT, García, XC, Millet, JP, Solchaga, VP, Elorza, EN, García, JT, de Santiago, AD, Márquez, RL, Gallardo, JFM, Galán, VG, Alonso, MM, Brusola, AG, Rey, RR, García, LA, Herrero, FS, Serrano, RG, Fullola, MG, Díez, MT, Zanon, TT, Portero, MF, García, PA, Lopez, AMS, Aznar, ML, Camprecios, JM, Saborit, N, Montalvá, AS. Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol. Bmj Open Respiratory Research. 2025; 12(1)DOI:10.1136/bmjresp-2024-002475. PMID:41360613. IF:3.400(Q2/3D).

09/02/2025 Megaprosthesis Infection by Bacteroides fragilis in a Patient With Ewing's Sarcoma: A Case Report and Literature Review

Martínez-Ysasis, Y, Simonetti, AF, Navarro, F. Megaprosthesis Infection by Bacteroides fragilis in a Patient With Ewing's Sarcoma: A Case Report and Literature Review. Clinical Case Reports. 2025; 13(2)DOI:10.1002/ccr3.70185. PMID:39931721. IF:(Q/D).

09/08/2021 Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

Mostaza, JM, Suarez, C, Cepeda, JM, Manzano, L, Sanchez, D, Mascaró J., Maestre Peiro, Ana. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation. BMC Cardiovascular Disorders. 2021; 21(1)DOI:10.1186/s12872-021-02019-0. PMID:34372782. IF:2.174(Q4/8D).

09/09/2023 Indoor falls and number of previous falls are independent risk factors for long-term mortality after a hip fracture.

Barceló M, Casademont J, Mascaró J, Gich I, Torres OH. Indoor falls and number of previous falls are independent risk factors for long-term mortality after a hip fracture.. AGING CLINICAL AND EXPERIMENTAL RESEARCH. 2023; 35(11)DOI:10.1007/s40520-023-02551-3. PMID:37688755. IF:3.400(Q2/5D).

01/01/2023 Validation of gout diagnosis in electronic primary care medical records: A population-based study.

Pou MA, Martinez-Laguna D, Estebanez JL, Aivar M, Gayarre R, Conesa A, Hoyo J, Carbonell C, Reyes C, Diaz-Torne C. Validation of gout diagnosis in electronic primary care medical records: A population-based study.. JOINT BONE SPINE. 2023; 90(6)DOI:10.1016/j.jbspin.2023.105628. PMID:37634875. IF:3.800(Q1/3D).

01/01/2023 The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.

Boleto G, Reiseter S, Hoffmann-Vold AM, Mirouse A, Cacoub P, Matucci-Cerinic M, Silvério-António M, Fonseca JE, Duarte AC, Pestana Lopes J, Riccieri V, Lescoat A, Le Tallec E, Castellví Barranco I, Tandaipan JL, Airó P, Kuwana M, Kavosi H, Avouac J, Allanore Y. The phenotype of mixed connective tissue disease patients having associated interstitial lung disease.. SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023; 63DOI:10.1016/j.semarthrit.2023.152258. PMID:37696231. IF:4.600(Q1/2D).

27/01/2026 Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry

Vidal-Montal, P, Fabregat, A, Altabás-González, I, Pego-Reigosa, JM, Hernández-Martínez, A, Rua-Figueroa, I, Salman-Monte, T, Moriano, C, Segura, BT, Vela, P, Pareja-Martínez, A, García-Cirera, S, García-Villanueva, MJ, Garrote-Corral, S, Heredia, S, Riancho-Zarrabeitia, L, Manrique-Arija, S, Bernárdez, J, Magallares, B, Torrente-Segarra, V, Frade-Sosa, B, Gómez-Puerta, JA, Martinez-Barrio, J, Narvaez, J. Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN Registry. Lupus Science & Medicine. 2026; 13(1)DOI:10.1136/lupus-2025-001825. PMID:41592907. IF:3.500(Q2/3D).

01/01/2026 Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry

Fernández-Lozano, D, Domínguez-Alvaro, M, Narváez, J, Garrido-Puñal, N, De Miguel, E, Estrada-Alarcon, P, Hernández-Rodríguez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, Martín, JS, Calvo, I, Aldasoro, V, Abasolo, L, Loricera, J, Moya-Alvarado, P, García-Villanueva, MJ, Sánchez-Alonso, F, Castañeda, S, Hernández, JL, Blanco, R. Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry. RHEUMATOLOGY. 2026; 65(1)DOI:10.1093/rheumatology/keaf689. PMID:41452742. IF:4.400(Q1/1D).

01/11/2025 Methotrexate-Induced Gouty Arthritis in Psoriatic Patient

Carmona-Rocha, E, Torné, CD, Alonso, AML, Puig, L. Methotrexate-Induced Gouty Arthritis in Psoriatic Patient. Actas Dermo-Sifiliograficas. 2025; 116(10)DOI:10.1016/j.ad.2024.02.050. PMID:40615030. IF:(Q/D).

01/05/2025 Sustained drug-free remission in giant cell arteritis

Narváez, J, Domínguez, M, Galíndez, E, Mendizábal, J, Abasolo, L, Lluch, J, Loricera, J, Garrido, N, Castañeda, S, Moya, P, Larena, C, Estrada, P, Galisteo, C, Frutos, AR, Sanjuan, FO, Salman, T, Rocha, MV, Iñiguez, CL, González, MG, Blanco, R. Sustained drug-free remission in giant cell arteritis. RHEUMATOLOGY. 2025; 64(5)DOI:10.1093/rheumatology/keae644. PMID:39589919. IF:4.400(Q1/1D).

01/09/2021 Recomendaciones SEPAR y nuevos retos sobre la vacuna contra la COVID-19 en las enfermedades respiratorias.

de la Rosa-Carrillo D, López-Campos JL, Blanco Aparicio M, Villar-Álvarez F. Recomendaciones SEPAR y nuevos retos sobre la vacuna contra la COVID-19 en las enfermedades respiratorias.. Vacunas. 2021; 22(3)DOI:10.1016/j.vacun.2021.05.001. PMID:34031633. IF:(Q/D).

01/01/2023 Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.

Almonacid Sánchez C, Blanco-Aparicio M., Domínguez-Ortega J., Giner Donaire J, Molina Paris J, Sánchez Marcos N, Plaza V.. Validation of the algorithm for the monitoring and control of asthma through telemedicine. The Consensus COMETA Project.. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY. 2023; 33(3)DOI:10.18176/jiaci.0841. PMID:35797114. IF:6.700(Q1/2D).

31/12/2025 Clustering patients with COVID-19 according to respiratory support requirements, and its impact on short- and long-term outcome (RECOVID study)

Menéndez, R, Méndez, R, Latorre, A, González-Jiménez, P, Peces-Barba, G, Molina-Molina, M, España, PP, Garcia, E, Consuegra-Vanegas, A, García-Clemente, MM, Panadero, C, Figueira-Gonçalves, JM, de la Rosa-carrillo, D, Sibila, O, Martinez-Pitarch, MD, Toledo-Pons, N, López-Ramírez, C, Almonte-Batista, W, Macias-Paredes, A, Villamon, M, Dominguez-alvarez, M, Pérez-Rodas, EN, Lázaro, J, Quirós, S, Cordovilla, R, Cano-Pumarega, I, Torres, A. Clustering patients with COVID-19 according to respiratory support requirements, and its impact on short- and long-term outcome (RECOVID study). Pulmonology. 2025; 31(1)DOI:10.1080/25310429.2024.2442175. PMID:39750717. IF:6.400(Q1/1D).

01/04/2025 Long COVID-19: Impact of a personalized rehabilitation program

Perrot, JC, Segura, M, Flotats, G, Closa, C, Gich, I, Garcia, C, Alba, A, Nadal, MJ, Pintor, A, Terra, J, Ramirez, E, Beranuy, M, Bascunana, H, Plaza, V, Gueell-Rous, MR. Long COVID-19: Impact of a personalized rehabilitation program. Rehabilitacion. 2025; 59(2)DOI:10.1016/j.rh.2025.100903. PMID:40156968. IF:(Q/D).

07/12/2023 Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a Post-hoc study of the ISAACC trial.

Pinilla L, Esmaeili N, Labarca G, Martinez-Garcia MÁ, Torres G, Gracia-Lavedan E, Mínguez O, Martínez D, Abad J, José Masdeu M, Mediano O, Muñoz C, Cabriada V, Duran-Cantolla J, Mayos M, Coloma R, Montserrat JM, de la Peña M, Hu WH, Messineo L, MohammadReza S, Wellman A, Redline S, Sands S, Barbé F, Sánchez-de-la-Torre M, Azarbarzin A. Hypoxic burden to guide CPAP treatment allocation in patients with obstructive sleep apnoea: a Post-hoc study of the ISAACC trial.. EUROPEAN RESPIRATORY JOURNAL. 2023; 62(6)DOI:10.1183/13993003.00828-2023. PMID:37734857. IF:17.000(Q1/1D).

01/12/2023 Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients.

Gómez-Olivas JD, Campos-Rodriguez F, Nagore E, Martorell A, García-Rio F, Cubillos C, Hernandez L, Banuls J, Arias E, Ortiz P, Cabriada V, Gardeazabal J, Montserrat JM, Carreres C, Masa JF, Gomez de Terreros J, Abad J, Boada A, Mediano O, Castillo-Garcia M, Chiner E, Landete P, Mayos M, Fortuno A, Barbe F, Sanchez-de-la-Torre M, Cano-Pumarega I, Perez-Gil A, Gomez-Garcia T, Cullen D, Somoza M, Formigon M, Aizpuru F, Oscullo G, Garcia-Ortega A, Almendros I, Farre R, Gozal D, Martinez-Garcia MA. Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients.. CHEST. 2023; 164(6)DOI:10.1016/j.chest.2023.06.012. PMID:37348828. IF:9.500(Q1/1D).

25/09/2023 Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.

Puente-Maestu L, Dávila I, Quirce S, Crespo-Lessmann A, Martínez-Moragón E, Sola J, Nieto ML, González-Barcala FJ, Cea-Calvo L, Sánchez-Jareño M, Rivas-Pardinas C, Domingo C. Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.. Erj Open Research. 2023; 9(5)DOI:10.1183/23120541.00425-2023. PMID:37753282. IF:4.300(Q1/3D).

02/01/2026 Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers

Oscullo, G, Méndez, R, Garcia-Ortega, A, Olveira, C, Giron, R, Garcia-Clemente, M, Maiz, L, Rosa, DDL, Martinez-Garcia, MA. Improving the multidimensional scoring systems in bronchiectasis: the role of cellular biomarkers. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2026; 30(1)DOI:10.5588/ijtld.25.0335. PMID:41482621. IF:3.100(Q2/4D).

01/01/2026 Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I

Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F, Sellarés, J. Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I. RESPIRATORY MEDICINE. 2026; 251DOI:10.1016/j.rmed.2025.108591. PMID:41418888. IF:3.100(Q2/4D).

01/01/2026 A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough

Domingo, C, Crespo-Lessmann, A, McGarvey, L. A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.07.020. PMID:40887323. IF:9.200(Q1/1D).

01/01/2026 Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD

Casanova, C, Gonzalez-Dávila, E, De Torres, JP, Cabrera, C, Cosio, BG, O'Donnel, DE, Martínez-Gonzalez, C, Solanes, I, Fuster, A, Gotera, C, Marin, A, Amado, C, Iscar, M, Marin, JM, Neder, JA, Feu, N, Soriano, JB, López-Campos, JL, Divo, M, Peces-Barba, G, Celli, BR. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.05.004. PMID:40447521. IF:9.200(Q1/1D).

01/01/2026 Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease

Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez-Alvarez, M, Villar, J, Carrizosa, X, Quero, S, Gabaldon, T, Willis, JR, Saus, E, Gea, J, Santos, S, Camps, P, Agusti, A, Monso, E, Sibila, O, Faner, R. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine. 2026; 123DOI:10.1016/j.ebiom.2025.106099. PMID:41483682. IF:10.800(Q1/1D).

01/12/2025 Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort

Betancor, D, Rial, MJ, Olaguibel, JM, Del Pozo, V, Puebla, MJA, Arismendi, E, Barroso, B, Bobolea, I, Cárdaba, B, Cañas, JA, Domínguez-Ortega, J, Crespo-Leshman, A, Cruz, MJ, de la Fuente, AG, González-Barcalai, FJ, Luna-Portac, JA, Martínez-Rivera, C, Mullol, J, Muñoz, X, Plaza, V, Quirce, S, Soto-Retes, L, Valverde-Monge, M, Sastre, J. Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.06.016. PMID:40707281. IF:9.200(Q1/1D).

01/12/2025 Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study

Rivas, DD, Martinez-Moragon, E, Plaza, V, Serrano, CC, Benchimol, C, Flores, HI, Sánchez-Cuéllar, S, Martinez-Pitarch, MD, Aracil, CF, Alonso, AT, Rebollo, JCS, Gambasica, ZV, Campos, RMD, Mulato, PT, Gimeno, IE, Laorden, D, Arismendi, E, Malanda, NM, Damia, AD, Galvan, MF, Dávila, I, Bobo, JOD, Cosio, BG, de Llano, LAP. Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.04.003. PMID:40348717. IF:9.200(Q1/1D).

01/12/2025 Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine

Pascual, MB, Zapata-Huizi, JJ, Ramos, D, Francesqui, J, Alsina-Restoy, X, Hernández-González, F, Sellares, J. Biomarkers in Sarcoidosis: From Traditional Markers to Precision Medicine. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. 2025; 46(06)DOI:10.1055/a-2741-2030. PMID:41213628. IF:2.700(Q2/5D).

01/09/2025 Phenotype Analysis of Chronic Bronchial Infection Patients on Inhaled Antibiotic Therapy: A Multicentre Retrospective Cohort Study in Spain (INBREATHING Study)

Moreno, BR, Benitez, ID, Erro, M, Burgos, J, Sayés, A, Garcia-Urrestarazu, EJ, Pou, C, Castan, RA, Navarro, A, Fuentes, AMD, Lakhani, JS, Juez-Garcia, I, Manzano, C, Santisteve, S, Morales, A, Monge, A, Moncusi-Moix, A, Sánchez-Cucó, A, Alcaide, AB, de-Torres, JP, Barbé, F, Suarez-Cuartin, G, de la Rosa, D, González, J. Phenotype Analysis of Chronic Bronchial Infection Patients on Inhaled Antibiotic Therapy: A Multicentre Retrospective Cohort Study in Spain (INBREATHING Study). ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(9)DOI:10.1016/j.arbres.2025.04.008. PMID:40350352. IF:9.200(Q1/1D).

01/09/2025 Imaging of Immunodeficiency-Associated Lymphoproliferative Disorders

Franquet, T, Brenes, JM, Radike, M, Giménez, A, Domingo, P. Imaging of Immunodeficiency-Associated Lymphoproliferative Disorders. SEMINARS IN ULTRASOUND CT AND MRI. 2025; 46(4)DOI:10.1053/j.sult.2025.06.001. PMID:40543829. IF:1.900(Q3/6D).

01/01/2026 The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization

Domingo, P, Stapleton, JT. The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization. AIDS. 2026; 40(1)DOI:10.1097/QAD.0000000000004369. PMID:41489321. IF:3.100(Q2/4D).

16/12/2025 Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration

Timiryasova, A, Greenberg, L, Domingo, P, Tarr, PE, Egle, A, Martin, C, Mussini, C, Wit, F, Cingolani, A, Lehmann, C, Castagna, A, Petoumenos, K, Sabin, CA, Bonnet, F, Lundgren, J, Bottanelli, M, Hosein, S, Carlander, C, Amstutz, A, Grabmeier-Pfistershammer, K, Garges, H, Marongiu, A, Young, LA, Peters, L, Ryom, L. Mortality and Non-Fatal Clinical Outcomes After the Most Common Cancers in People with HIV: A Multicohort Collaboration. Cancers. 2025; 17(24)DOI:10.3390/cancers17244000. PMID:41463249. IF:4.400(Q2/3D).

01/10/2025 A plague like no other: beyond the buboes in Thucydides' account of the Plague of Athens

Domingo, P, Prieto, P, Pons, L. A plague like no other: beyond the buboes in Thucydides' account of the Plague of Athens. CLINICAL MICROBIOLOGY AND INFECTION. 2025; 31(10)DOI:10.1016/j.cmi.2025.05.001. PMID:. IF:8.500(Q1/1D).

01/10/2025 Efficacy and tolerability of BIC/TAF/FTC in people with HIV and solid and hematological neoplasms: a multicenter observational study (BIKONCO study)

Monforte, A, Imaz, A, Ferrer, J, Piatti, C, Molero, M, Rodríguez, A, Stable, CE, Navarro, M, Prieto, P, Domingo, P, Crespo, M, Güerri-Fernández, R, Moltó, J, Navarro, J. Efficacy and tolerability of BIC/TAF/FTC in people with HIV and solid and hematological neoplasms: a multicenter observational study (BIKONCO study). HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/10/2025 High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study

Peters, L, Bannister, W, Sridhar, G, Gardizi, M, van Frankenhuijsen, M, De Scheerder, MA, Johansen, IS, Viard, JP, Duvivier, C, Bogner, J, Degen, O, Castagna, A, Staub, T, Martinez, E, Domingo, P, Moreno, S, Reikvam, DH, Parczewski, M, Knysz, B, Shivkar, Y, Brown, K, van Wyk, J, Vannappagari, V. High effectiveness and rare virologic failure in treatment-experienced individuals on long-acting cabotegravir plus rilpivirine therapy across Europe: Insights from the EuroSIDA study. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/10/2025 Virological non-inferiority and lower weight gain with DTG/3TC versus BIC/FTC/TAF: 96-week final results from the PASO-DOBLE (GeSIDA 11720) randomised, multicentre, openlabel, non-inferiority trial

Masia, M, Domingo, P, Curran, A, Guerri-Fernandez, R, Bernal, E, Bravo, J, Revollo, B, Macias, J, Tiraboschi, JM, Montejano, R, Amador, C, Garcia-Fraile, L, Blanco, JL, Ryan, P, Torralba, M, Merino, D, Diaz-Brito, V, Galindo, MJ, Ferra, S, Villoslada, A, Losa, JE, Fanjul, FJ, Perez-Stachowski, X, Peraire, J, Portilla, J, de la Fuente, S, Dueñas, C, Vazquez, MJ, Di Gregorio, S, Gil, P, de Miguel, M, Alejos, B, Martinez, E. Virological non-inferiority and lower weight gain with DTG/3TC versus BIC/FTC/TAF: 96-week final results from the PASO-DOBLE (GeSIDA 11720) randomised, multicentre, openlabel, non-inferiority trial. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/10/2025 Hepatocellular carcinoma screening in HIV/HBV coinfected individuals: insights from Spain, Germany, and Poland

Berenguer, J, Ryan, P, Lutz, T, Martin-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, J, De los Santos, I, Esser, S, Morano, LE, López, I, Valencia, J, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Fariñas, C, Raczynska, A, Voit, F, Qurishi, N, Noe, S, Reus, S, Khaykin, P, Schneeweiss, S, Wandeler, G, Boyd, A, De Miguel, M, Bellón, JM, Parczewski, M, Rockstroh, J. Hepatocellular carcinoma screening in HIV/HBV coinfected individuals: insights from Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

01/10/2025 Prevalence and factors associated with liver cirrhosis in people with HIV and chronic hepatitis B: a cross-sectional study in Spain, Germany, and Poland

Ryan, P, Berenguer, J, Lutz, T, Martín-Carbonero, L, Pérez-Latorre, L, Vivancos, MJ, Navarro, J, Navarro-Soler, R, Ferrero, OL, Palacios, R, Wyen, C, Domingo, P, Monin, M, Camino, X, Montero-Alonso, M, Killer, A, Malin, JJ, De los Santos, I, Esser, S, Morano, LE, López, I, Cuevas, G, Vogelmann, R, Mauss, S, Rivero, A, Elamouri, F, Hidalgo-Tenorio, C, Cielniak, I, Van Bremen, K, Pérez-Somarriba, J, Sanz, J, Rozplochowski, B, Beer, D, Baumgarten, A, Haberl, A, Galindo, MJ, Armiñanzas, C, Raczynska, A, Voit, F, Qurishi, N, Christensen, S, Szymczak, A, Hlebowicz, M, Schwarze-zander, C, Jessen, A, Boyd, A, De Miguel, M, Bellon, JM, Parczewski, M, Rockstroh, J. Prevalence and factors associated with liver cirrhosis in people with HIV and chronic hepatitis B: a cross-sectional study in Spain, Germany, and Poland. HIV MEDICINE. 2025; 26DOI:. PMID:. IF:3.200(Q2/4D).

15/09/2025 Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV

Quesada-López, T, Mestres-Arenas, A, Domingo, P, Prieto, P, Mur, I, Pérez, JAH, Guimaraes, MP, Villarroya, J, Gutiérrez, MD, Mateo, MG, Domingo, JC, Planavila, A, Villarroya, F, Giralt, M, Cereijo, R. Reduced circulating levels of CXCL14 are associated with cardiovascular damage in people living with HIV. EUROPEAN JOURNAL OF PHARMACOLOGY. 2025; 1003DOI:10.1016/j.ejphar.2025.177996. PMID:40714072. IF:4.700(Q1/2D).

03/10/2023 Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.

Scévola S, Niubó J, Domingo P, Verdejo G, Curran A, Diaz-Brito V, Peñafiel J, Tiraboschi J, Morenilla S, Garcia B, Soriano I, Podzamczer D, Imaz A. Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.. JOURNAL OF INFECTIOUS DISEASES. 2023; 228(7)DOI:10.1093/infdis/jiad304. PMID:37526315. IF:(Q/D).

05/09/2023 Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.

González-Cordón A, Assoumou L, Moyle G, Waters L, Johnson M, Domingo P, Fox J, Stellbrink HJ, Guaraldi G, Masiá M, Gompels M, De Wit S, Florence E, Esser S, Raffi F, Behrens G, Pozniak A, Gatell JM, Martínez E. Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2023; 78(9)DOI:10.1093/jac/dkad247. PMID:37539492. IF:3.900(Q1/3D).

01/10/2023 Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.

Lasaga M, Río P, Vilas-Zornoza A, Planell N, Navarro S, Alignani D, Fernández-Varas B, Mouzo D, Zubicaray J, Pujol RM, Nicoletti E, Schwartz JD, Sevilla J, Ainciburi M, Ullate-Agote A, Surrallés J, Perona R, Sastre L, Prosper F, Gomez-Cabrero D, Bueren JA. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.. HAEMATOLOGICA. 2023; 108(10)DOI:10.3324/haematol.2022.282418. PMID:37021532. IF:10.100(Q1/2D).